07:00 , Mar 18, 2013 |  BC Week In Review  |  Company News

Cantab Biopharmaceuticals, PolyTherics deal

PolyTherics said it received an undisclosed milestone payment from the Cantab subsidiary of Celtic Pharma Holdings Advisors LLP. PolyTherics said the milestone was triggered by further progress on a 2010 hematology deal with Cantab to...
08:00 , Nov 12, 2012 |  BC Week In Review  |  Company News

Medical Research Council pharmaceuticals news

The U.K.'s three-year, £180 million ($285.8 million) Biomedical Catalyst fund awarded £39 million ($62.4 million) across 10 universities and 22 small and medium sized enterprises (SMEs) for early stage life science research. Companies receiving funding...
07:00 , Mar 29, 2010 |  BC Week In Review  |  Company News

Antitope, Cantab Biopharmaceuticals deal

Antitope will generate a high-yielding manufacturing mammalian cell line to develop a "biosuperior" protein therapeutic for a hematologic indication for Cantab. Further terms were not disclosed. Antitope Ltd. , Cambridge, U.K.   Cantab Biopharmaceuticals Ltd....
08:00 , Feb 1, 2010 |  BC Week In Review  |  Company News

Cantab Biopharmaceuticals management update

Cantab Biopharmaceuticals Ltd. , Cambridge, U.K.   Business: Biosimilars   Hired: Jim Mills as CEO, formerly director of operations at Cambridge Biomanufacturing Ltd.  ...
08:00 , Feb 1, 2010 |  BC Week In Review  |  Company News

Cantab Biopharmaceuticals, PolyTherics deal

The companies will use PolyTherics' TheraPEG pegylation technology to develop an undisclosed preclinical protein therapeutic in the area of hematology. Celtic Pharma Holdings Advisors LLP, which owns Cantab, has options to add two additional proteins...
08:00 , Feb 1, 2010 |  BC Week In Review  |  Company News

Cantab Biopharmaceuticals board of directors update

Cantab Biopharmaceuticals Ltd. , Cambridge, U.K.   Business: Biosimilars   Appointed: Bill Henry, partner at Celtic Pharma Holdings Advisors LLP, as non-executive director; John Mayo, partner at Celtic Pharma Holdings Advisors LLP, as non-executive director;...
08:00 , Feb 1, 2010 |  BC Week In Review  |  Financial News

Cantab Biopharmaceuticals completes venture financing

Cantab Biopharmaceuticals Ltd. , Cambridge, U.K.   Business: Biosimilars   Date completed: 1/25/10   Type: Venture financing   Raised: £5 million ($8.1 million)   Investor: Celtic Pharma Holdings Advisors LLP   Note: Celtic committed to...
01:50 , Jan 27, 2010 |  BC Extra  |  Company News

PolyTherics, Cantab in hematology deal

PolyTherics Ltd. (London, U.K.) partnered with Cantab Biopharmaceuticals Ltd. (Cambridge, U.K.) to develop an undisclosed protein therapeutic in preclinical development in the area of hematology. The collaboration will use PolyTherics' TheraPEG pegylation technology to enhance...
01:52 , Jan 26, 2010 |  BC Extra  |  Financial News

Cantab gets L5 million from Celtic Pharma

Cantab Biopharmaceuticals Ltd. (Cambridge, U.K.) received a L5 million ($8.1 million) investment from Celtic Pharma Holdings Advisors LLP. Cantab is developing enhanced versions of marketed, off-patent biologics. Cantab will initially focus on hematology candidates, which...